MATTHEW D PERRY
CIK 1454337 · last filed 2026-05-26
MATTHEW D PERRY is a corporate insider who has filed 22 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for XOMAP, was dated May 26, 2026. Across all open-market trades the lifetime net is +$5.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.19M
3
22
$5.00M
Holdings By Company
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | XOMAP | Grant (A) | +3,586 | $0 | EDGAR |
| 2025-05-23 | XOMAP | Grant (A) | +5,971 | $0 | EDGAR |
| 2024-05-17 | XOMAP | Grant (A) | +6,070 | $0 | EDGAR |
| 2023-06-26 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | −43,139 | -$392.6K | EDGAR |
| 2023-05-19 | XOMAP | Grant (A) | — | $0 | EDGAR |
| 2023-04-07 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-20 | XOMAP | Grant (A) | — | $0 | EDGAR |
| 2022-03-11 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-21 | XOMAP | Grant (A) | — | $0 | EDGAR |
| 2021-03-12 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |